Ignite Creation Date:
2024-05-05 @ 4:35 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00270517
Status:
UNKNOWN
Last Update Posted:
2006-09-19
First Post:
2005-12-23
Brief Title:
Comparative Study of EDP-420 Versus Another Antibiotic in the Treatment of Community Acquired Pneumonia
Sponsor:
Enanta Pharmaceuticals Inc
Organization:
Enanta Pharmaceuticals Inc
Study Overview
Official Title:
A Randomized Double-Blinded Parallel Group Multicenter Study of EDP-420 Versus Telithromycin for the Treatment of Community Acquired Pneumonia
Status:
UNKNOWN
Status Verified Date:
2006-09
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will compare the efficacy safety and tolerability of EDP-420 versus another oral antibiotic in the treatment of community acquired pneumonia
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None